Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
2.700
-0.160 (-5.59%)
Dec 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -21.24 | -37.64 | -19.48 | -8.52 | -6.56 | 1.05 | Upgrade
|
| Depreciation & Amortization | 0.15 | 0.12 | 0.11 | 0.03 | 0 | 0 | Upgrade
|
| Other Amortization | 0.83 | 0.33 | 0.49 | 0.59 | 0.54 | 0.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.21 | 0.3 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 21.54 | 21.22 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 6.82 | 0.99 | 0.63 | 0.87 | 0.3 | 0.68 | Upgrade
|
| Other Operating Activities | -25.93 | 1.2 | 6.27 | -0.1 | -0.44 | -8.69 | Upgrade
|
| Change in Accounts Payable | -0.85 | -0.7 | 0.8 | 0.52 | 0.24 | 0.13 | Upgrade
|
| Change in Other Net Operating Assets | -1.02 | 0.23 | -1.56 | 0.13 | -0.15 | 0.16 | Upgrade
|
| Operating Cash Flow | -20.91 | -13.95 | -12.74 | -6.47 | -6.05 | -6.03 | Upgrade
|
| Capital Expenditures | -1.56 | -0.01 | -0.09 | -0.09 | -0.01 | - | Upgrade
|
| Sale of Property, Plant & Equipment | 1.22 | 5.53 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | 1.08 | 5.31 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.34 | 6.6 | 5.21 | -0.09 | -0.01 | - | Upgrade
|
| Short-Term Debt Issued | - | 4.97 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 0.68 | - | 0.57 | 3.99 | Upgrade
|
| Total Debt Issued | - | 4.97 | 0.68 | - | 0.57 | 3.99 | Upgrade
|
| Long-Term Debt Repaid | - | -0.26 | -0.89 | - | - | -3.99 | Upgrade
|
| Net Debt Issued (Repaid) | -0.02 | 4.71 | -0.21 | - | 0.57 | 0.01 | Upgrade
|
| Issuance of Common Stock | 83.82 | 12 | 0 | 14.01 | 6.99 | 6.08 | Upgrade
|
| Other Financing Activities | -0.27 | -0.27 | - | -0.94 | -0.85 | -0.08 | Upgrade
|
| Financing Cash Flow | 83.53 | 16.44 | -0.21 | 13.08 | 6.7 | 6 | Upgrade
|
| Net Cash Flow | 62.28 | 9.09 | -7.74 | 6.51 | 0.64 | -0.02 | Upgrade
|
| Free Cash Flow | -22.47 | -13.96 | -12.84 | -6.57 | -6.06 | -6.03 | Upgrade
|
| Free Cash Flow Per Share | -0.76 | -1.99 | -5.78 | -4.04 | -6.55 | -8.89 | Upgrade
|
| Cash Interest Paid | 0.2 | 0.2 | 0.33 | 0.04 | 0.12 | 0.37 | Upgrade
|
| Cash Income Tax Paid | 0 | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -15.71 | -10.91 | -9.44 | -3.28 | -3.81 | -18.49 | Upgrade
|
| Unlevered Free Cash Flow | -15.52 | -10.67 | -9.51 | -3.39 | -3.91 | -18.5 | Upgrade
|
| Change in Net Working Capital | 6.18 | 3.32 | -1.29 | -0.7 | 0.28 | 15.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.